Stock Events

Stock Events

PeptiDream 

¥1,211
9
-¥18-1.46% Friday 06:30

Statistics

Day High
1,227
Day Low
1,195.5
52W High
2,029
52W Low
1,131.5
Volume
1,038,300
Avg. Volume
1,068,516
Mkt Cap
157.44B
P/E Ratio
77.28
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 11
¥75
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.13
-0.06
0
0.07
Expected EPS
-0.02922272
Actual EPS
N/A

Financials

32.17%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
93.35BRevenue
30.03BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4587.TSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap42.29B
Alnylam Pharmaceuticals specializes in RNAi therapeutics, competing in the novel drug discovery space similar to PeptiDream's peptide-based discoveries.
Ionis Pharmaceuticals
IONS
Mkt Cap12.35B
Ionis Pharmaceuticals focuses on RNA-targeted drug discovery, presenting competition in the innovative therapeutic area.
CRISPR Therapeutics
CRSP
Mkt Cap4.75B
CRISPR Therapeutics is a leader in gene editing, a cutting-edge area of biotech where PeptiDream could see indirect competition in drug development.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.67B
BioMarin Pharmaceutical focuses on rare disease treatments, overlapping with PeptiDream's interest in novel, hard-to-treat conditions.
Vertex Pharmaceuticals
VRTX
Mkt Cap111.43B
Vertex Pharmaceuticals is known for its work in treating cystic fibrosis and other serious diseases, areas where PeptiDream's technology could also make an impact.
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Regeneron Pharmaceuticals is a biotech company that develops monoclonal antibodies, a direct competitor in the field of biologic drug development.
AMGEN
AMGN
Mkt Cap187.56B
Amgen is a biopharmaceutical giant with a broad portfolio, including innovative therapeutics that could compete with PeptiDream's developments.
Novo Nordisk
NVO
Mkt Cap164.13B
Novo Nordisk is a global healthcare company with a strong focus on diabetes and obesity, areas where PeptiDream's peptide technology could offer novel treatments.

About

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
Show more...
CEO
Dr. Patrick Crawford Reid Ph.D.
Employees
680
Country
Japan
ISIN
JP3836750004

Listings

MX
MX
4587N.MX
OTC Link
US
PPTDF
TSE
JP
4587.TSE

0 Comments

Share your thoughts

FAQ

What is PeptiDream stock price today?▼
The current price of 4587.TSE is ¥1,211 JPY — it has decreased by -1.46% in the past 24 hours. Watch PeptiDream stock price performance more closely on the chart.
What is PeptiDream stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PeptiDream stocks are traded under the ticker 4587.TSE.
Is PeptiDream stock price growing?▼
4587.TSE stock has fallen by -1.58% compared to the previous week, the month change is a -20.07% fall, over the last year PeptiDream has showed a -35% decrease.
What is PeptiDream market cap?▼
Today PeptiDream has the market capitalization of 157.44B
When is the next PeptiDream earnings date?▼
PeptiDream is going to release the next earnings report on May 13, 2026.
What were PeptiDream earnings last quarter?▼
4587.TSE earnings for the last quarter are -4.03 JPY per share, whereas the estimation was -5.58 JPY resulting in a +27.83% surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is PeptiDream revenue for the last year?▼
PeptiDream revenue for the last year amounts to 93.35B JPY.
What is PeptiDream net income for the last year?▼
4587.TSE net income for the last year is 30.03B JPY.
Does PeptiDream pay dividends?▼
Yes, 4587.TSE dividends are paid annual. The last dividend per share was 75 JPY. As of today, Dividend Yield (FWD)% is 0%.
How many employees does PeptiDream have?▼
As of April 11, 2026, the company has 680 employees.
In which sector is PeptiDream located?▼
PeptiDream operates in the Health & Wellness sector.
When did PeptiDream complete a stock split?▼
The last stock split for PeptiDream was on June 28, 2017 with a ratio of 2:1.
Where is PeptiDream headquartered?▼
PeptiDream is headquartered in Kawasaki, Japan.